CCDRD AG´s medical and pharmacokinetic experts have established and already verified a clinical development strategy for both products.
The strategy has been presented, discussed and verified in scientific advice procedures with the following regulatory agencies:
- European Medical Agency (EMA)
- Paul-Ehrlich-Institute (PEI)